Results 151 to 160 of about 516,689 (292)

Loss of Calponin 2 causes premature ovarian insufficiency in mice

Background Premature ovarian insufficiency (POI) is a condition defined as women developing menopause before 40 years old. These patients display low ovarian reserve at young age and difficulties to conceive even with assisted reproductive technology ...
Jian-Ping Jin, Tzu-Bou Hsieh
core   +1 more source

Can we predict menopause and premature ovarian insufficiency?

Fertility and Sterility
The prediction of menopause and premature ovarian insufficiency (POI) involves understanding the factors that contribute to the timing of these events.
J. Laven, Y. Louwers
semanticscholar   +1 more source

Impact of diabetes mellitus on the menopausal experience: A scoping review

Diabetic Medicine, EarlyView.
Abstract Aims To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE,
Rachel Black, Felicity Hasson, Lisa King, Mark Davies, Deborah Muldrew, Paul Slater, Jenny Johnston, Dawn Adams, Rhonda Murphy, George Kernohan, Vivien Coates   +10 more
wiley   +1 more source

HEP14-activated PKC-ERK1/2 pathway boosts HEP14-empowered hADSCs for ovarian regeneration and functional restoration

Communications Biology
Premature ovarian insufficiency (POI) and age-related natural-aging ovarian insufficiency (ARNA-OI) pose pressing global health challenges, necessitating effective therapeutic strategies and a deep understanding of their underlying mechanisms. This study
Jiajia Sun, Qin Zhong, Kan Liu, Qili Sun, Chunan Lu, Yingtong Di, Lin Bai, Helen Picton, Bin Tang, Xiaojiang Hao, Liming Gui   +10 more
doaj   +1 more source

Tissue engineering and stem cell-based therapeutic strategies for premature ovarian insufficiency.

Regenerative Therapy
Premature ovarian insufficiency (POI), also known as premature ovarian failure (POF), is a complex endocrine disease that commonly affects women under the age of 40.
Fatemeh Kuchakzadeh, Jafar Ai, S. Ebrahimi-Barough   +2 more
semanticscholar   +1 more source

Menopause and comorbidity assessment in cisgender women living with HIV in Victoria: A clinic record review of women seen at three tertiary centres in Melbourne, Australia

HIV Medicine, EarlyView.
Abstract Background Data on women ageing with HIV in Australia are limited, particularly regarding those in midlife and experiencing menopause. The aim of this study is to describe the demographic characteristics of cisgender women living with HIV who attend the Alfred Hospital, Monash Medical Centre and Melbourne Sexual Health Centre for primary HIV ...
Anna B. Pierce, Sushena Krishnaswamy, Philip Rawson‐Harris, Wajeeha Fatima, Melanie Bissessor, Jennifer F. Hoy   +5 more
wiley   +1 more source

Premature Ovarian Insufficiency Is Associated with Increased Risk of Depression, Anxiety, and Poor Life Quality: A Systematic Review and Meta-analysis

ALPHA PSYCHIATRY
Background: Premature ovarian insufficiency (POI) seriously affects the reproductive health of women. Several studies have been conducted to show that POI appears to be associated with psychological and psychosocial problems, but whether POI increases ...
Yichang Tian, Xueqian Zhang, Z. Xin, Chiang-Shan R. Li, Fengyu Zhang, Hu Deng, Xiaokui Yang   +6 more
semanticscholar   +1 more source

Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination

, 2014
Three young women who developed premature ovarian insufficiency following quadrivalent human papillomavirus (HPV) vaccination presented to a general practitioner in rural New South Wales, Australia.
Deirdre Therese Little MBBS, DRANZCOG, FACRRM, Harvey Rodrick Grenville Ward Bsc(Med), MBChB, DMCOG, FCOG(SA), MMed (O&G), FRANZCOG   +1 more
core   +1 more source

Evidence Map Analysis on Randomized Controlled Trials: Chinese Patent Medicines and Classic Traditional Chinese Medicine Prescriptions

Journal of Evidence-Based Medicine, EarlyView.
ABSTRACT Objectives To evaluate the status and methodological quality of randomized controlled trials published in 2024 on Chinese patent medicines and Classic Traditional Chinese Medicine Prescriptions, providing evidence for clinical practice and policy.
Xiaolei Wu, Yazi Zhang, Jinji Zhao, Haiyin Hu, Alice Josephine Fauci, Myeong Soo Lee, Zifan Sang, Danni Li, Ni Qin, Tianhui Sun, Jiaqi Yu, Menglong Shi, Boli Zhang, Junhua Zhang, Zhaochen Ji   +14 more
wiley   +1 more source

Risk and outcomes of adrenal crisis in primary adrenal insufficiency: Evidence from a 24‐year nationwide cohort study

Journal of Internal Medicine, EarlyView.
Abstract Background Adrenal crisis is a life‐threatening emergency. Despite preventive strategies, previous reports suggest increasing incidence and substantial mortality, but robust validated data are limited. Objective To assess temporal trends in adrenal crisis incidence and identify associated risk factors.
Ann‐Elin Meling Stokland, Lars Breivik, Ingvild Dalen, Sandra Dis Steintorsdottir, Simon Kildal, Ingrid Nermoen, Kari Lima, Margrethe Svendsen, Åse Bjorvatn Sævik, Aleksandra Debowska, Stina Therese Sollid, Daniel Hannisdal, Trine Elisabeth Finnes, Agnes Judit Horvath, Elin Korsgaard, Hallvard Singsås, Bjørn O. Åsvold, Maria Eriksson Steigen, Sigrid Blika, Petya Milova, Anders Svare, Anja Fog Heen, Lene Katrine Bjerke, Marianne Stedje, Siri Carlsen, Bjørn Gunnar Nedrebø, Anders Palmstrøm Jørgensen, Grethe Å. Ueland, Marianne Øksnes, Eystein Sverre Husebye   +29 more
wiley   +1 more source